Skip to Content

Lacosamide Pregnancy and Breastfeeding Warnings

Lacosamide is also known as: Vimpat

Lacosamide Pregnancy Warnings

UCB, Inc. has established the UCB AED Pregnancy Registry to advance scientific knowledge about safety and outcomes in pregnant women being treated with lacosamide. To ensure broad program access and reach, either a healthcare provider or the patient can initiate enrolment in the UCB AED Pregnancy Registry by calling 1-888-537-7734. Physicians are also advised to recommend that pregnant patients taking lacosamide enroll in the North American Antiepileptic Drug Pregnancy Registry. This can be done by calling 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at

Lacosamide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of increased embryofetal mortality, perinatal mortality, and growth deficit. There are no controlled data in human pregnancy. Lacosamide should only be given during pregnancy when benefits outweigh risks.

See references

Lacosamide Breastfeeding Warnings

There are no data on the excretion of lacosamide into human milk. Because many drugs are excreted into human milk, a decision should be made whether to discontinue nursing or to discontinue lacosamide, taking into account the importance of the drug to the mother.

Animal studies have reported that lacosamide and/or its metabolites are excreted into milk.

See references

References for pregnancy information

  1. "Product Information. Vimpat (lacosamide)." UCB Pharma Inc, Smyrna, GA.

References for breastfeeding information

  1. "Product Information. Vimpat (lacosamide)." UCB Pharma Inc, Smyrna, GA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.